Understanding the Rationale, Mechanism of Action, and Resistance Mechanisms for PARP Inhibition in MBC

Download this slideset from a live symposium reviewing the mechanisms of action and resistance of PARP inhibitors used in cancer treatment.
Judy E. Garber, MD, MPH
Jennifer K. Litton, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.71 MB
Released: December 6, 2018


Jointly provided by National Comprehensive Cancer Network (NCCN) and Clinical Care Options, LLC

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0283 (Fax)
For Clinicians:
For Patients:

This activity is supported by educational grants from
Pfizer Inc.

Related Content

Results from BYLieve Cohort A with alpelisib plus fulvestrant in PIK3CA¬-mutated HR+/HER2- advanced breast cancer post-CDK4/6i, from ASCO 2020 as reported by Clinical Care Options (CCO)

Released: June 3, 2020

Survival analysis from MONALEESA-3/-7 of ribociclib plus ET for HR+/HER2- breast cancer with visceral metastases from ASCO 2020 as reported by Clinical Care Options (CCO)

Released: June 3, 2020

CNS activity of tucatinib plus trastuzumab/capecitabine in HER2+ metastatic breast cancer from ASCO 2020 as reported by Clinical Care Options (CCO)

Released: June 2, 2020

Updated results from phase IIIb CompLEEment-1 study of ribociclib and letrozole in HR+, HER2- advanced breast cancer from ASCO 2020, as reported by Clinical Care Options (CCO)

Released: June 1, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?